Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coronavirus Infectious Disease 2019 (COVID-19)”

163 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 163 results

Testing effectiveness (Phase 2)Ended earlyNCT04834908
What this trial is testing

Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection

Who this might be right for
SARS-CoV-2 Infection
Bharat Serums and Vaccines Limited 7
Testing effectiveness (Phase 2)Study completedNCT04537949
What this trial is testing

A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults

Who this might be right for
Covid-19Protection Against COVID-19
BioNTech SE 96
Not applicableStudy completedNCT04339998
What this trial is testing

Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS)

Who this might be right for
Coronavirus InfectionCOVIDCovid-19+1 more
University of Minnesota 129
Early research (Phase 1)Ended earlyNCT05075304
What this trial is testing

A Safety and Tolerability Study of BDB-001 in Mild, Moderate COVID-19 Patients

Who this might be right for
COVID-19
Staidson (Beijing) Biopharmaceuticals Co., Ltd 18
Post-approval studies (Phase 4)Temporarily pausedNCT04334967
What this trial is testing

Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care

Who this might be right for
COVID-19Corona Virus InfectionSARS-CoV-2+2 more
Providence Health & Services 13
Large-scale testing (Phase 3)Ended earlyNCT04508023
What this trial is testing

Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
Janssen Research & Development, LLC 1,284
Not applicableStudy completedNCT04760990
What this trial is testing

Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort.

Who this might be right for
Multiple SclerosisCOVID-19 (Severe Coronavirus Disease 2019)
University Hospital, Basel, Switzerland 1,181
Not applicableUnknownNCT04452942
What this trial is testing

Cytokine and Eicosanoid Mediators in Coronavirus Disease 2019 (COVID-19)

Who this might be right for
COVID-19
EicOsis Human Health Inc. 30
Testing effectiveness (Phase 2)Ended earlyNCT04442230
What this trial is testing

NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19)

Who this might be right for
Coronavirus Infection
Altimmune, Inc. 48
Not applicableStudy completedNCT04588363
What this trial is testing

COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Multisystem Inflammatory Syndrome in Children (MIS-C)Coronavirus Disease 2019 (COVID-19)
National Institute of Allergy and Infectious Diseases (NIAID) 244
Large-scale testing (Phase 3)Study completedNCT04939428
What this trial is testing

Study of MK-4482 for Prevention of Coronavirus Disease 2019 (COVID-19) in Adults (MK-4482-013)

Who this might be right for
Coronavirus Disease (COVID-19)
Merck Sharp & Dohme LLC 2,441
Not applicableUnknownNCT04447144
What this trial is testing

Nutritional Habits, and Coronavirus Disease 2019 (COVID-19) Outcome

Who this might be right for
Covid19Chronic InflammationNon-Communicable Chronic Diseases
Cairo University 200
Not applicableUnknownNCT04563156
What this trial is testing

Follow-up and Rehabilitation of Survivors of Severe Coronavirus Disease 2019 (COVID-19) Infection

Who this might be right for
Covid19
University of Sao Paulo General Hospital 100
Not applicableUnknownNCT04279782
What this trial is testing

Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection

Who this might be right for
Coronavirus
Third Affiliated Hospital, Sun Yat-Sen University 100
Early research (Phase 1)Study completedNCT06291883
What this trial is testing

Evaluation of KGR Prescriptions in Suppressing COVID-19 Infection.

Who this might be right for
Coronavirus Disease 2019Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Sheng-Teng Huang 26
Not applicableStudy completedNCT04797091
What this trial is testing

Kidney in Coronavirus Disease 2019 Registry

Who this might be right for
Corona Virus InfectionSARS-CoV 2
University of Cologne 500
Not applicableUnknownNCT04380662
What this trial is testing

Risk Factors Worsening COVID19 for Out-patient With Home Monitoring

Who this might be right for
Covid19
University Hospital, Grenoble 800
Not applicableStudy completedNCT06043882
What this trial is testing

Number of Participants Diagnosed With Sarcoidosis by Bronchoscopic Transbronchial Needle Aspiration After COVID- 2019 .

Who this might be right for
SarcoidosisCOVID-19
Ain Shams University 55
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05017298
What this trial is testing

Clinical Study for Subjects With COVID-19 Using Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells

Who this might be right for
Corona Virus InfectionCovid19
Celltex Therapeutics Corporation 30
Testing effectiveness (Phase 2)Study completedNCT04649021
What this trial is testing

Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population

Who this might be right for
SARS-CoV-2
BioNTech SE 960
Load More Results